Hovione Ventures
ABOUT HOVIONE VENTURES
Hovione Ventures is a Lisbon-based corporate venture capital firm founded in 2015 and backed by the shareholders of Hovione, one of Portugal's largest pharmaceutical companies. It invests €200K to €1M at pre-seed and seed stage in life sciences and health tech, including therapeutics, medtech, and digital health, leveraging Hovione's pharma expertise for diligence and portfolio support. The firm's portfolio includes CellmAbs, which it counts among its exits, alongside Anybrain, Adapttech, Delox, SolasCure, Vaxdyn, and Oxular. Hovione Ventures is chaired by Peter Villax. By pairing early-stage capital with the scientific and manufacturing knowledge of an established pharma group, Hovione Ventures supports founders building therapeutics, medical devices, and digital health platforms with the technical diligence that its corporate backing makes possible.
INVESTMENT THESIS
Early-stage life sciences: therapeutics, medtech, digital health. Leverages Hovione's pharma expertise for diligence and support.
INVESTMENT DETAILS
FREQUENTLY ASKED QUESTIONS
What stage does Hovione Ventures invest at?
Hovione Ventures invests at Pre-Seed, Seed stages.
What is Hovione Ventures's typical ticket size?
Hovione Ventures typically writes cheques of €200K–€1M.
What sectors does Hovione Ventures invest in?
Hovione Ventures focuses on Life Sciences, HealthTech.
Where is Hovione Ventures based?
Hovione Ventures is a CVC based in Lisbon, Portugal, founded in 2015.
Who are the partners at Hovione Ventures?
Key people at Hovione Ventures include Peter Villax (Chairman).
What companies has Hovione Ventures invested in?
Hovione Ventures's portfolio includes Anybrain, CellmAbs, Adapttech, Delox, SolasCure, Vaxdyn, Oxular.
How do I contact or pitch Hovione Ventures?
You can reach Hovione Ventures via their website (hovioneventures.com). You can also submit your startup through Portugal VC's pitch tool to be forwarded to matching investors.